Surprise as drugs company chief steps down
Mr Brandon will be replaced by Tony Richardson, who moves from his current position of chief financial officer.
The surprise announcement came as Alltracel reported strong second quarter revenues of €1.1 million, more than four times revenues in the same quarter last year. Revenues for the first six months of 2004 were €2 million, up from €498,000 in 2003. Shares in Alltracel, which are traded on London's Alternative Investment Market (AIM), rose 9% to 24.5p yesterday.
